Allianz Asset Management GmbH grew its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 143.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 147,453 shares of the company’s stock after acquiring an additional 86,813 shares during the period. Allianz Asset Management GmbH owned about 0.30% of Nu Skin Enterprises worth $1,797,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Prescott Group Capital Management L.L.C. lifted its position in Nu Skin Enterprises by 24.4% during the second quarter. Prescott Group Capital Management L.L.C. now owns 1,734,608 shares of the company’s stock valued at $13,860,000 after purchasing an additional 340,000 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Nu Skin Enterprises by 7.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock worth $9,582,000 after buying an additional 88,088 shares during the period. American Century Companies Inc. raised its stake in shares of Nu Skin Enterprises by 28.9% in the second quarter. American Century Companies Inc. now owns 1,222,833 shares of the company’s stock worth $9,770,000 after buying an additional 274,123 shares during the period. Geode Capital Management LLC lifted its position in shares of Nu Skin Enterprises by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 1,175,049 shares of the company’s stock valued at $9,391,000 after buying an additional 21,276 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Nu Skin Enterprises by 9.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company’s stock valued at $6,105,000 after acquiring an additional 65,060 shares during the period. 82.84% of the stock is currently owned by hedge funds and other institutional investors.
Nu Skin Enterprises Stock Up 0.4%
Shares of NYSE NUS opened at $10.21 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.45 and a debt-to-equity ratio of 0.26. Nu Skin Enterprises, Inc. has a 12-month low of $5.32 and a 12-month high of $14.62. The firm’s 50-day moving average price is $10.37 and its 200-day moving average price is $10.65. The stock has a market capitalization of $497.88 million, a price-to-earnings ratio of 4.68 and a beta of 1.01.
Nu Skin Enterprises News Roundup
Here are the key news stories impacting Nu Skin Enterprises this week:
- Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share, payable Mar. 11, 2026 — supports income-focused investors. Nu Skin Enterprises Announces Quarterly Dividend
- Positive Sentiment: Company says Q4 and full-year 2025 results were within guidance and cites >50% growth in earnings for 2025 — a positive signal on profitability trends despite top-line pressure. Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
- Neutral Sentiment: Company published the Q4 press release and slide deck (useful for investor due diligence on segment/region detail). Q4 Press Release Slide Deck
- Negative Sentiment: Q4 results missed estimates: EPS $0.29 vs. consensus $0.30 and revenue $370.3M vs. $382.7M — shows near-term top-line weakness and a modest EPS shortfall. Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Miss Estimates
- Negative Sentiment: Forward guidance is well below consensus: Q1 FY26 EPS guide of $0.10–$0.20 (consensus ~$0.29) and revenue $320–340M (consensus ~$382.7M); FY26 EPS guide $0.80–1.20 vs. consensus ~$1.42 — the guidance cut is the primary driver of downward pressure. Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
- Negative Sentiment: Analyst preview noted FX headwinds and heightened competition that pressured revenue guidance and contributed to the company’s conservative outlook. Nu Skin Gears Up to Report Q4 Earnings: What’s in the Offing?
Analyst Ratings Changes
A number of equities research analysts have commented on the stock. Zacks Research upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research note on Friday, January 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Thursday, January 22nd. Finally, Wall Street Zen downgraded shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold”.
Read Our Latest Stock Analysis on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.
Founded in 1984 by Blake M.
See Also
- Five stocks we like better than Nu Skin Enterprises
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
